LocumDeck
0161 504 8999
info@nasgp.org.uk
A guideline from Nice recommends that omalizumab can be considered in chronic urticaria.
© 2024 NASGP
Amelia House, Crescent Road, Worthing, BN11 1QR 0161 504 8999 info@nasgp.org.uk
Design by James Walker | Built by UnitedUs